: A nasal pharmaceutical composition incorporates a non-toxic agent which is capable of increasing the ciliary function e.g. caffeine and at least partially antagonising the ciliary function depressant effect of the active agent e.g. dihydroergotamine or any other constituent present in the composition.
展开▼